Covered recipient · General Payments record
PRAVIN M KHEMANI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$191,697.23
- Reported across 261 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,730.00 | 5 |
| Education | $699.00 | 1 |
| Food and Beverage | $313.87 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $5,485.63 | 3 |
| Cala Health, Inc. | $4,250.00 | 3 |
| Amneal Pharmaceuticals LLC | $699.00 | 1 |
| Ipsen Biopharmaceuticals, Inc | $166.90 | 3 |
| Medtronic, Inc. | $74.57 | 1 |
| ABBVIE INC. | $50.22 | 2 |
| Teva Pharmaceuticals USA, Inc. | $16.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.04 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064980 | CMS |
| ABBVIE INC. | $28.18 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104064982 | CMS |
| Amneal Pharmaceuticals LLC | $699.00 | 08/14/2024 | Education | Undisputed | 01/23/2026 | 1139191460 | CMS |
| Biogen, Inc. | $2,055.00 | 04/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104806981 | CMS |
| Biogen, Inc. | $5.63 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104808501 | CMS |
| Biogen, Inc. | $3,425.00 | 07/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104831656 | CMS |
| Cala Health, Inc. | $1,250.00 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082354239 | CMS |
| Cala Health, Inc. | $1,500.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082354241 | CMS |
| Cala Health, Inc. | $1,500.00 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082354243 | CMS |
| Ipsen Biopharmaceuticals, Inc | $64.45 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091951081 | CMS |
| Ipsen Biopharmaceuticals, Inc | $25.00 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091951077 | CMS |
| Ipsen Biopharmaceuticals, Inc | $77.45 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091951079 | CMS |
| Medtronic, Inc. | $74.57 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119325871 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.55 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151544185 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.